Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis: The ADAPT Randomized Clinical Trial. (2020)
Attributed to:
A randomised placebo-controlled study examining the role of anti-IgE in severe recalcitrant paediatric atopic eczema
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1001/jamapediatrics.2019.4476
PubMed Identifier: 31764962
Publication URI: http://europepmc.org/abstract/MED/31764962
Type: Journal Article/Review
Volume: 174
Parent Publication: JAMA pediatrics
Issue: 1
ISSN: 2168-6203